Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic. [electronic resource]
Producer: 20120716Description: 315-23 p. digitalISSN:- 1931-8405
- Adenine -- analogs & derivatives
- Adult
- Anti-HIV Agents -- therapeutic use
- Atazanavir Sulfate
- CD4 Lymphocyte Count
- Central African Republic -- epidemiology
- DNA Fingerprinting
- Drug Resistance, Viral -- drug effects
- Female
- Genetic Variation
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- therapeutic use
- HIV-1 -- drug effects
- Health Services Accessibility -- statistics & numerical data
- Humans
- Lopinavir -- therapeutic use
- Male
- Oligopeptides -- therapeutic use
- Organophosphonates -- therapeutic use
- Prospective Studies
- Pyridines -- therapeutic use
- RNA, Viral -- drug effects
- Reverse Transcriptase Inhibitors -- therapeutic use
- Tenofovir
- Viral Load -- drug effects
- Young Adult
- Zidovudine -- therapeutic use
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.